UroGen Pharma
URGN | NASDAQ
$28.10
+$1.92 (+7.33%)
At close: Nov 16, 2026, 4:00 PM ET
$27.54
-$0.56 (-1.99%)
After-hours:
Nov 16, 2026, 7:30 PM ET
UroGen Pharma Statistics
Key statistics explainedMarket Data
$1.38B
$1.48B
1.64
894.61K
50.56M
5.2%
84.47%
NASDAQ
IL0011407140
Price Performance
-18.7%
-42.8%
-1.7%
20.0%
18.6%
125.5%
115.2%
-18.7%
18.3%
13.9%
6.8%
Valuation
-21.29
10.08
-0.18
0.22
5.51
2.60
-11.01
-10.44
-9.10
-10.77
5.93
-35.36
-37.20
-11.24
-4.7%
-9.6%
-11.0%
Financial Health
$98.8M
$196.28M
$90.55M
$271.87M
3.40
3.06
-1.57
-4.92
-1.49
-0.67
-0.98
-2.01
3
Margins & Profitability
91.4%
-12.4%
-15.9%
-26.3%
-52.8%
-60.5%
7.7%
-14.6%
Returns
-24.2%
54.0%
-15.5%
-15.6%
-24.2%
Historical Growth (CAGR)
48.0%
44.4%
31.7%
34.6%
22.9%
0.8%
-14.6%
-13.6%
-15.8%
Analyst Forecasts
Buy
5
187.9%
49.0%
Mar 1, 2027
$0.41
-175.9%
$107.09M
183.0%
Fair Value Estimates
N/A
N/A
N/A
N/A
$58.00
106.4%
Cash Flow
$-131.85M
$-132.05M
$-151.38M
-$2.61
-$2.61
-52.7%
Income Statement
$250.25M
$228.75M
$-30.94M
$-39.89M
$-65.75M
-$1.32
$834.18K
$-219.17K
300
Add to Watchlist
Select watchlists to add or remove URGN